Advertisment

Unveiling the Impact of Obesity on Public Health: A European Study

author-image
Safak Costu
New Update
Unveiling the Impact of Obesity on Public Health: A European Study

In an epoch-making moment, a European study delving into the implications of obesity on public health was unveiled yesterday. This revelation transpired as part of the annual Panhellenic Conference on Health Economics and Policies, featuring notable participation from two Greek scientists.

Advertisment

Unmasking Obesity's Impact

The study, which has found a home in the esteemed International Journal of Obesity, throws light on various facets of obesity and related disorders. Nikhil Dhurandhar, a prominent figure in the obesity research domain, was honored with the George A. Bray Founders Award for his significant strides in understanding and treating this global health issue.

The investigation zeroes in on the effects of obesity, in combination with metabolic irregularities, on the readmission rates of non-Hodgkin's lymphoma (NHL) patients. The findings underscore that metabolic anomalies, even in the absence of obesity, elevate the likelihood of non-elective readmission among these patients. The study accentuates the urgency to minimize non-elective readmission in NHL patients, particularly by addressing metabolic abnormalities.

Advertisment

Emerging Anti-Obesity Medications

The annual ObesityWeek conference cast the spotlight on the latest anti-obesity medications, evaluating their effectiveness and safety. The conference paraded data on tirzepatide and semaglutide, underscoring their potential for long-term weight management. However, it also instigated discussions on the necessity of intensive lifestyle modifications in the era of highly potent weight management drugs.

Weight Regain Post Bariatric Surgery

Advertisment

A systematic review and meta-analysis centered on weight regain following bariatric surgery and its associated predictors. The analysis emphasized the paramountcy of sustained lifestyle alterations to ensure the effectiveness and efficacy of the surgery.

The analysis also discussed the high adherence rates of patients to Novo Nordisk's weight-loss drug Wegovy, juxtaposed to older medicines like Contrave and Qsymia. It spotlighted the success of Wegovy in curtailing obesity and the hurdles of non-persistence with older anti-obesity medications.

Excessive Body Weight and Running Kinetics

The study probed into the repercussions of excessive body weight and foot pronation on running kinetics. It underlined the impact of excessive body weight on ground reaction forces during running and the adaptations in running patterns by individuals with excessive body weight.

This European study, in conjunction with the contributions of Greek scientists, signals a significant stride in understanding the multifaceted impact of obesity on public health. It offers a lens into the complexities of this global health crisis, and the ongoing efforts in its mitigation.

Advertisment
Advertisment